LL-37, Antimicrobial Peptide, human – 1 mg

Overview

Experience the power of LL-37, a human antimicrobial peptide that plays a crucial role in your body’s first line of defense against infections. This peptide, which belongs to the cathelicidin family, is a vital component in combatting both local infections and systemic pathogen invasions. LL-37 is the first amphipathic alpha-helical peptide isolated from humans, providing effective protection at sites of inflammation and wounds. With its unique structure and function, LL-37 is not only cytotoxic to pathogenic bacteria but also exhibits a significant resistance to proteolytic degradation in solution.

Key Features

• Human-derived antimicrobial peptide
• First line of defense against infections
• Highly resistant to proteolytic degradation
• Cytotoxic to bacteria and normal eukaryotic cells
• Amphipathic alpha-helical structure

Specifications

FAQ

What is LL-37 used for?

LL-37 is utilized primarily for its antimicrobial properties, aiding in the body’s defense against infections, particularly in wounds and inflamed areas.

How is LL-37 administered?

LL-37 can be administered in various ways depending on research needs, including topical applications and inclusion in assays. Explore our PKG substrate for more application insights.

Is LL-37 safe for use in research?

Yes, LL-37 is considered safe for research applications. It has been extensively studied for its role in immune response and infection control.

Investing in LL-37 means you are choosing a product that stands at the forefront of antimicrobial research. It’s perfect for those working on immunology, microbiology, or related fields. Don’t miss out on enhancing your research with this critical peptide. Add LL-37 to your laboratory today.

Related Products

• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.